clinical trial · NCT06529432
A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic Surgery
Jiangsu HengRui Medicine Co., Ltd.·phase2·recruiting·n = 96
Local Analgesia Via Nerve BlockBupivacaine Liposome InjectionBupivacaine Hydrochloride Injection
brief summary
The objective of this study is to evaluate the efficacy, safety, and tolerability of bupivacaine liposomes for paravertebral nerve block in the treatment of thoracoscopic postoperative pain, and to evaluate the relevant human pharmacokinetics.
started
Mar 3, 2026
primary completion
Nov 1, 2026
completion
Nov 1, 2026
last updated
Mar 12, 2026
official title
Efficacy, Safety and Pharmacokinetics of Bupivacaine Liposome Injection for Paravertebral Nerve Block in the Treatment of Postoperative Pain After Thoracoscopic Surgery: a Multicenter, Randomized, Double-blind, Dose-finding, Positive Control, Phase Ⅱ Clinical Trial
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol